Profil bibliographique

Denise A. Yardley

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

561Publications signalées

27566Citations signalées

3Affiliations récentes

Les institutions déclarées

Sarah Cannon Research Institute Sarah Cannon Tennessee Oncology

Les domaines associés

Advanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyBreast Cancer Treatment StudiesMonoclonal and Polyclonal Antibodies Research

Les publications récentes

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Fig. S1 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Fig. S2 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Fig. S5 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Fig. S6 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Fig. S3 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Fig. S4 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Fig. S8 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Fig. S7 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

Accès ouvert 2025 supplementary-materials OpenAlex

Supplementary Table S1 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Francisco Hermida‐Prado, Yingtian Xie, Shira Sherman, Zsuzsanna Nagy et autres

0 citations

2025 article OpenAlex

Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial

Anna Weiss, Qingchun Jin, Nabihah Tayob, Eileen Wrabel et autres

us (code pays fourni par la source)

5 citations Annals of Surgical Oncology

Accès ouvert 2025 article OpenAlex

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival

John Crown, Daniil Stroyakovskii, Denise A. Yardley, Chiun‐Sheng Huang et autres

ie, ru, us, tw, de, kr, es, cn, au (code pays fourni par la source)

43 citations ESMO Open

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.